PRICE T ROWE ASSOCIATES INC /MD/
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 80255
BALTIMORE, MD
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,113,665
+$901,268 QoQ
Shares Held
266,877
+27.7% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. XERS ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
68,214,436 | $1,083,245,243 | |
| 2 | ALKS |
Alkermes plc.
|
6,737,328 | $353,035,986 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,903,354 | $211,158,092 | |
| 4 | LQDA |
Liquidia Corp
|
1,940,364 | $154,705,221 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
243,444 | $131,905,262 | |
| 6 | PRGO |
PERRIGO Co plc
|
8,700,421 | $90,397,373 | |
| 7 | ZTS |
Zoetis Inc.
|
1,139,097 | $81,855,510 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,679,152 | $56,889,668 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,113,665 | 266,877 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,212,397 | 209,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,361,684 | 173,463 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,357,654 | 166,788 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $715,775 | 153,271 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $968,397 | 176,393 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $577,933 | 170,482 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $458,781 | 160,976 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $294,678 | 130,968 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $277,653 | 125,635 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $270,257 | 115,003 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $209,850 | 112,823 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $289,297 | 110,419 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $200,455 | 122,979 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $163,562 | 122,979 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $161,630 | 103,609 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,416 | 36,634 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,440 | 24,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,211 | 12,700 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||